Drug details

Stiolto Respimat (tiotropium bromide and olodaterol)

type of Respiratory Inhalant Combos, Respiratory Inhalant Combos

Stiolto Respimat (tiotropium bromide and olodaterol) inhalation spray is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:
  • palpitations,
  • dizziness,
  • blurred vision,
  • cough,
  • itching,
  • constipation,
  • dry mouth,
  • insomnia,
  • nosebleed,
  • rash,
  • hives, 
  • urinary retention,
  • back pain,
  • joint pain or swelling,
  • dry skin,
  • sinus infection,
  • fast heart rate,
  • difficulty urinating, and 
  • high blood pressure,
  • glaucoma,
  • dehydration,
  • oral thrush,
  • difficulty swallowing,
  • urinary tract infection.
  • gastroesophageal reflux disease (GERD),
  • sinus irritation and sore throat (nasopharyngitis),
  • difficulty speaking,
  • laryngitis,
  • gum disease,
  • swollen lips or tongue,
  • skin infection,
The following drugs are related to Stiolto Respimat, either as a replacement or used together:
  • Tudorza Pressair (aclidinium bromide)
  • VoSpire ER (albuterol sulfate extended-release tablets)
  • Proair HFA (albuterol sulfate inhalation aerosol)
  • Ventolin HFA (albuterol sulfate inhalation aerosol)
  • Arcapta Neohaler (indacaterol inhalation powder)
  • Brovana (arformoterol tartrate inhalation solution)
  • Bevespi Aerosphere (glycopyrrolate and formoterol fumarate inhalation aerosol)
  • Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)
  • Symbicort (budesonide and formoterol fumarate dihydrate)
  • Daliresp (roflumilast)
  • Seebri Neohaler (glycopyrrolate inhalation powder, for oral inhalation use)
  • Utibron Neohaler (indacaterol and glycopyrrolate inhalation powder, for oral inhalation use)
  • Xopenex HFA (levalbuterol tartrate inhalation aerosol)
  • Striverdi Respimat (olodaterol inhalation spray)
  • Yupelri (revefenacin inhalation solution)
  • Spiriva Respimat (tiotropium bromide inhalation spray)
  • Tezspire (tezepelumab-ekko injection, for subcutaneous use)